About 1 result found for searched term "2225109-03-3" (0.227 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M24997 | Tafolecimab | PCSK9 |
| IBI-306 | ||
| Tafolecimab (IBI-306) is a human lgG2 monoclonal antibody that specifically binds PCSK-9 and reduces LDL-C levels by inhibiting PCSK-9-mediated endocytosis of the LDL receptor, which in turn enhances clearance of LDL-C and leads to a reduction in LDL-C levels. Tafolecimab may be used in studies of hypercholesterolaemia. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
